Inpharma 1652 - 23 Aug 2008

■ First four-drug study for multiple myeloma (MM)announced. The Multiple Myeloma ResearchConsortium has announced the initiation of a four-drug combination study for patients with newly-diagnosed MM. The four drugs in the study are:lenalidomide, IV bortezomib, IV doxorubicinliposomal, and dexamethasone.The Multiple Myeloma Research Consortium. The Multiple MyelomaResearch Consortium (MMRC) Announces Initiation of First Four-DrugCombination Study to Treat Newly Diagnosed Multiple Myeloma Patients.Media Release : 14 Aug 2008. Available from: URL: http://www.themmrc.org 809092140

1

Inpharma 23 Aug 2008 No. 16521173-8324/10/1652-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved